Stock search

Ticker or company name

IDXX card

IDXX price forecast

Idexx Laboratories$700,65

P/E now is 47,2. Average over 5 years: 49,3 (range 41–54). The stock is 4% below its history.

Base · FY2030

$1 013,69+9,4% a year

The base case gives 9,4% a year, below your target of 10%.

Settings

%

No analyst consensus: assumptions come from the company's last 5 years. Change any in the table.

Assumptions by year

FY2026FY2027FY2028FY2029FY2030
Revenue growth, %
Net margin, %
Change in shares, %
Payout ratio, %
P/E low
P/E base
P/E high
Revenue$4,72 bn$5,18 bn$5,68 bn$6,24 bn$6,84 bn
Net income$1,07 bn$1,18 bn$1,29 bn$1,42 bn$1,56 bn
EPS$13,45$14,96$16,63$18,50$20,58

Changed values are highlighted. Bear and bull cases: growth ∓ 5,5%, margin ∓ 2 pp, low and high P/E.

Price at year end

  • Base
  • Bear – Bull
  • now $700,65

The dot is the base case, the line runs from bear to bull, the dashed line is today's price.

Result at the end of FY2030

Bear$601,69

Price change
−14,1%
A year
−3,6%
Fair value today
$406,31
Margin of safety
−42,0%

Base$1 013,69

Price change
+44,7%
A year
+9,4%
Fair value today
$684,52
Margin of safety
−2,3%

Bull$1 545,18

Price change
+120,5%
A year
+21,2%
Fair value today
$1 043,42
Margin of safety
+48,9%

What growth the price implies

For the stock to return 10% a year, revenue must grow 10,2% a year to FY2030 at a 22,8% margin and P/E 49,3.

Growth over 5 years
9,7%
Analyst consensus
no data
In your model
9,7%

Calculated from your assumptions. Not an investment recommendation.

Base · FY2030$1 013,69+9,4% a year